Skip to main content

Frances M. Jagla

Chair of Trademark Practice Group

Fran Jagla is the chair of the firm's trademark practice group, a member of the firm's executive committee, and the executive member of the firm's DEI Council. Fran advises clients across a wide range of industries, from Fortune 100 companies to startups, in all areas of trademark law. Fran focuses her practice in assisting clients with both U.S. and foreign trademark matters, including name development, search, clearance, filing, registration, maintenance, licensing, and due diligence, as well as a strong focus on regulatory issues, and with the enforcement of trademarks and copyrights.

Fran provides vital counsel to clients navigating the complexities of brand approval and protection for companies in the pharmaceutical and other highly regulated industries, including medical devices, wine and spirits, cannabis and beyond. She also advises clients in trademark-related acquisitions, divestitures, licensing, and Internet domain name matters.

Fran has previously served as in-house counsel for some of the nation’s leading corporations. Her experience gained from working on both sides of the client-attorney relationship makes her uniquely qualified to develop the practical, business-centric solutions to address her clients’ needs.

Fran is a member of the International Trademark Association (INTA), and the Intellectual Property Owners Association (IPO), where she currently serves as a member on the organization’s International Trademark Law & Practice Committee.  She is recognized by World Trademark Review in their guide WTR 1000 – The World’s Leading Trademark Professionals as “excellent in the deal space” and as having “successfully overseen many IP-rich acquisition, spin-off and divestiture transactions.”  She is also named to Managing Intellectual Property's IP Stars and is included in the list of Washington Super Lawyers and in the list of The Best Lawyers in America. Fran is a thought leader in trademark law, regularly presenting or writing on related legal and industry topics.

+ Expand All
  • Professional Experience

    • Christensen O’Connor Johnson KindnessPLLC
      Seattle, WA, 2020 – present
    • Lane Powell PC
      Seattle, WA, 2012 – 2020
    • Leydig, Voit & Mayer Ltd.
      Chicago, IL, 2008 – 2012
    • Law Office of Frances M. Jagla, PLLC
      Sammamish, WA, 2007 – 2008
    • Microsoft Corporation
      Redmond, WA, 2004 – 2007
    • Abbott Laboratories
      Abbott Park, IL, 1989 – 2004
    • Miles, Inc.
      Elkhart, IN, 1984 – 1989
  • Professional Affiliations

    • American Bar Association
    • Indiana University Alumni Association
    • Intellectual Property Owners Association (IPO)
      Member, International Trademark Law & Practice Committee
    • International Trademark Association (INTA)
    • Pharmaceutical Trade Marks Group
    • Washington State Bar Association
      Member, Intellectual Property Section
      Former Member, Executive Committee - Intellectual Property Section
  • Representative Experience

    • Acquisition of Knoll AG
      Counseled Abbott Laboratories in the acquisition of Knoll AG.*
    • Divestiture of Abbott Laboratories’ Animal Health and Agriculture Divisions
      Conducted the divestiture of Abbott Laboratories’ Animal Health and Agriculture Divisions.*
    • Abbott Laboratories’ Hospital Products Spin-Off
      Coordinated spin-off of Abbott Laboratories’ hospital products division into Hospira.*
    • Incyte Corporation Trademark and Related Advice
      Representing Incyte Corporation in coordinating all trademark clearance, registration, enforcement and licensing.*
    • Merrimack Pharmaceuticals Spin-off
      Provided IP counseling to Merrimack Pharmaceuticals relating to the divestiture of the Onivyde® product to Ipsen Biopharmaceuticals.*



    (*indicates represented while at another firm)

  • Presentations & Publications


    • "Timely Topics in IP Law: NFTs,” Washington State Bar Association; moderator (Seattle, WA, September 2021).
    • “NFTs: Why? NO REALLY, Why?” Presentation to the Association of Corporate Counsel of Washington; moderator (Seattle, WA, May 2021).
    • "Overview of the Madrid System for International Registration of Trade Marks," Intellectual Property Owners Association webcast; panelist (Seattle, WA, February 2021).
    • "The Impact of COVID-19 on Trademark Prosecution and Examination," Intellectual Property Owners Association webcast; panelist (Seattle, WA, May 2020).
    • “Trademarks: Exploring the Cannabis Pipeline,” Law Seminars International, Technology Law & Artificial Intelligence Conference (Seattle, WA, December 2018).
    • “Up in Smoke: Exploring the Cannabis Pipeline,” Pharmaceutical Trade Marks Group Annual Conference (Dubrovnik, Croatia, October 2018).
    • “Protecting Your Liquid Assets Using Intellectual Property,” Washington State Bar Association (Seattle, WA, April 2018).
    • “From ‘No Way’ to ‘Here’s How’” Law Seminars International, Technology Law Conference; moderator (Seattle, WA, December 2017).
    • “Securing Rights in Intangible Property Through Trademark, Copyrights, Patents and Trade Secrets,” National Business Institute, Law Seminar webcast (Seattle, WA, December 2016).
    • “Trademark License Agreements — Can You Have an Alcoholic Beverage Brand Without a License?” National Business Institute, Law Seminar webcast (Seattle, WA, December 2016).
    • “Hands off! Protecting Your Intellectual Property,” University of Washington School of Law, Hospitality and Travel Law Symposium (Seattle, WA, April 2016).
    • “As the World Turns — International Trademark Developments,” International Trademark Association Roundtable (Seattle, WA, April 2016).
    • “Trademark Issues in Regulated Industries,” International Trademark Association and Office of Harmonization for Internal Market, Industry Seminar; moderator (Alicante, Spain, October 2015).
    • “Mad about Madrid: New Strategies for International Trademarks,” Managing Intellectual Property webinar; panelist (Seattle, WA, September 2015).
    • “Managing Global Enforcement Matters,” International Trademark Association Roundtable (Seattle, WA, February 2015).
    • “Your Identity: Getting It Right From the Start,” Puget Sound Business Journal, Startups and Emerging Companies Seminar (Seattle, WA, December 2014).
    • “Using Madrid Protocol — Risks and Rewards,” International Trademark Association Annual Conference; panelist (Hong Kong, China, May 2014).




    • “Cannabis Marks in Jeopardy – Is Your Industry Next?” World Trademark Review, 2017, pp. 54–57, Jagla, F.M, Scola, A., Wesner, G.F.
    • “Intellectual Property: Should You File Trademark Applications On Your Own?” Seattle Business Magazine, 2015, p. 29, Jagla, F.M., Connors, T.S.
    • “POM Wonderful: The New Prescription for False Advertising,” World Trademark Review: Pharmaceutical Trademarks 2015/2016 Global Guide, 2015, pp. 13-18, Jagla, F.M., Swanson, P.D, Wesner, G.F.
    • “Navigating Trademark Issues in the Pharmaceutical Field,” Aspatore Book, “Navigating Drug and Medical Device Legal Issues: Leading Lawyers on Handling Trademark, Fraud, and Liability Concerns (Inside the Minds),” 2014, pp. 7–18,
      Jagla, F.M.


    • J.D., Valparaiso University, 1984
    • B.A., Political Science, Indiana University, 1981

Bar & Court Admissions

    • Bar Admissions: Indiana (inactive), Washington
    • United States District Court for the Western District of Washington
Back To All Professionals